Drug News

Zacks Investment Research Analysts Give Alere Inc (NYSE: ALR) an “Underperform” Rating

January 4, 2011   ·   0 Comments

diagnostics and health management solutions. The Company’s products and services are focused on infectious disease, cardiology, oncology, drugs of abuse and women’s health. Its brands range from over-the-counter tests to lab-based diagnostics to
Moreover Technologies – Search results for… drugs – 30 of 764 returned


Readers Comments (0)

You must be logged in to post a comment.